![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Tecilazich Francesco
Publisher: Informa Healthcare
ISSN: 1472-8214
Source: Expert Opinion on Emerging Drugs, Vol.18, Iss.2, 2013-06, pp. : 207-217
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Emerging drugs for diabetic neuropathy
By Tahrani Abd A Askwith Trevor Stevens Martin J
Expert Opinion on Emerging Drugs, Vol. 15, Iss. 4, 2010-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Emerging drugs for diabetic retinopathy
Expert Opinion on Emerging Drugs, Vol. 13, Iss. 4, 2008-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Emerging drugs for diabetic retinopathy
By Pipis Antonios Scholl Stefan Augustin Albert J
Expert Opinion on Emerging Drugs, Vol. 16, Iss. 4, 2011-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Treatment for diabetic leg ulcers costly in the US
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 464, 2004-01 ,pp. :